Can Real-World Data Help Overcome Cancer’s Financial Toxicity?

Cancer, second only to heart disease, is one of the most expensive conditions to treat. Costs for treatment continue to rise and this can affect patients adversely through a phenomenon know as financial toxicity (FT). Studies utilizing real-world evidence (RWE), real-world data (RWD) and clinical research have established FT as a major factor that can affect the outcomes and quality of life of patients suffering from different cancers and receiving specific treatments. An emerging body of published evidence suggests treatment-related expenses can drastically affect patient well-being and clinical outcomes. Read more here.

(Source: Daniel Vorobiof, Managed Healthcare Executive, September 15, 2020)